BTTX
NASDAQBetter Therapeutics Inc.
Latest news
25 items- SECSEC Form EFFECT filed by Better Therapeutics Inc.EFFECT - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form EFFECT filed by Better Therapeutics Inc.EFFECT - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form EFFECT filed by Better Therapeutics Inc.EFFECT - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form EFFECT filed by Better Therapeutics Inc.EFFECT - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form EFFECT filed by Better Therapeutics Inc.EFFECT - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form POS AM filed by Better Therapeutics Inc.POS AM - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form POS AM filed by Better Therapeutics Inc.POS AM - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form POS AM filed by Better Therapeutics Inc.POS AM - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form POS AM filed by Better Therapeutics Inc.POS AM - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form POS AM filed by Better Therapeutics Inc.POS AM - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form S-8 POS filed by Better Therapeutics Inc.S-8 POS - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form S-8 POS filed by Better Therapeutics Inc.S-8 POS - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form 25-NSE filed by Better Therapeutics Inc.25-NSE - Better Therapeutics, Inc. (0001832415) (Subject)
- SECSEC Form 424B3 filed by Better Therapeutics Inc.424B3 - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form 8-K filed by Better Therapeutics Inc.8-K - Better Therapeutics, Inc. (0001832415) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Cue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came out 2 days ago. Aclarion (NASDAQ:ACON) shares increased by 10.39% to $0.44. The market value of their outstanding shares is at $3.1 million. BioSig Technologies (NASDAQ:BSGM) shares increased by 9.39% to $0.58. The market value of their outstanding shares is at $5.4 million. OptiNose (NASDAQ:OPTN) stock increased by 9.09% to $2.04. The company's market cap stands at $229.8 million. SCWorx (NASDAQ:WORX) stock rose 7.55% to $1.85. The market value of their outstanding shares is at $2.2 million
- NEWSWhy Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day SessionShares of Jabil Inc. (NYSE:JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates. Jabil posted adjusted earnings of $1.68 per share, beating estimates of $1.66 per share. The company’s quarterly sales came in at $6.77 billion, missing expectations of $6.89 billion. Jabil shares dipped 14.2% to $126.56 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Verb Technology Company, Inc. (NASDAQ:VERB) shares jumped 189% to $0.4047. VERB's MARKET.live launched Facebook and Instagram social shopping technology integration. Better Therapeutics, Inc. (NASDAQ:BTTX) surged 108
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Better Therapeutics (NASDAQ:BTTX) shares increased by 65.4% to $0.06 during Friday's regular session. The market value of their outstanding shares is at $3.1 million. Carmell (NASDAQ:CTCX) shares rose 38.52% to $3.2. The market value of their outstanding shares is at $73.8 million. P3 Health Partners (NASDAQ:PIII) stock rose 38.23% to $0.98. The market value of their outstanding shares is at $112.5 million. Akebia Therapeutics (NASDAQ:AKBA) shares rose 28.1% to $1.75. The market value of their outstanding shares is at $330.6 million. The company's, Q4 earnings came out yesterday. Acrivon Therapeutics (NASDAQ:ACRV) shares increased by 26.03% to $6.39. The market value of their ou
- NEWSNasdaq Down Over 100 Points; Hibbett Reports Downbeat SalesU.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.28% to 38,797.24 while the NASDAQ fell 0.67% to 16,020.07. The S&P 500 also fell, dropping, 0.58% to 5,120.59. Check This Out: Top 5 Industrials Stocks That May Fall Off A Cliff In Q1 Leading and Lagging Sectors Energy shares jumped by 0.6% on Friday. In trading on Friday, information technology shares fell by 1.2%. Top Headline Hibbett Inc (NASDAQ:HIBB) reported downbeat fourth-quarter sales and issued weak guidance. Hibbett reported fourth-quarter FY24 sales growth of 1.8% year-on-year to $466.59 million, m
- SECSEC Form 424B3 filed by Better Therapeutics Inc.424B3 - Better Therapeutics, Inc. (0001832415) (Filer)
- SECSEC Form 8-K filed by Better Therapeutics Inc.8-K - Better Therapeutics, Inc. (0001832415) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's Pre-Market SessionGainers Better Therapeutics (NASDAQ:BTTX) shares increased by 85.4% to $0.06 during Friday's pre-market session. The market value of their outstanding shares is at $3.5 million. Madrigal Pharmaceuticals (NASDAQ:MDGL) shares moved upwards by 22.34% to $298.0. The market value of their outstanding shares is at $5.9 billion. Akebia Therapeutics (NASDAQ:AKBA) stock rose 16.05% to $1.59. The market value of their outstanding shares is at $299.5 million. As per the press release, Q4 earnings came out yesterday. Rallybio (NASDAQ:RLYB) shares increased by 15.98% to $1.85. The company's market cap stands at $69.9 million. The company's, Q4 earnings came out 3 days ago. Avalo Therapeutics (NASDAQ
- NEWSWhy Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving PremarketShares of Cardlytics, Inc. (NASDAQ:CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings. Cardlytics posted adjusted earnings of 14 cents per share, beating market estimates of 12 cents per share, according to data from Benzinga Pro. The company said it sees first-quarter revenue of $70 million to $73 million, versus expectations of $66.46 million. Cardlytics shares jumped 36.6% to $11.18 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Fisker Inc. (NYSE:FSR) shares rose 31.3% to $0.2034 in pre-market trading. Fisker shares dipped around 52% on Thursday following a Wall Street Jou
- NEWSDow Dips Over 100 Points; Dick's Sporting Goods Earnings Top ViewsU.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28. The S&P 500 also fell, dropping, 0.25% to 5,152.46. Check This Out: Tesla To $165? Here Are 10 Top Analyst Forecasts For Thursday Leading and Lagging Sectors Energy shares jumped by 0.8% on Thursday. In trading on Thursday, real estate shares fell by 2.4%. Top Headline Dick’s Sporting Goods Inc (NYSE:DKS) reported better-than-expected fourth-quarter results and issued strong guidance. Dick’s Sporting Goods reported fourth-quarter FY23 sales growth of 7.8% year-on-year to $3
- NEWSWhy Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of Limbach Holdings, Inc. (NASDAQ:LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. Limbach said it sees FY24 revenue of $510 million to $530 million, versus market estimates of $541.1 million. Limbach shares dipped 14.7% to $42.42 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Aptorum Group Limited (NASDAQ:APM) shares climbed 91% to $8.27. Presto Automation Inc. (NASDAQ:PRST) shares jumped 65.2% to $0.3715 after jumping 15% on Wednesday. Cheer Holding, Inc. (NASDAQ:CHR) surged 43.3% to $3.77 following full year 2023 financial results.
BTTX FAQ
7 questionsWhat does Better Therapeutics Inc. do?
Better Therapeutics, Inc. develops prescription digital therapeutics that delivers behavioral therapy, and creates feedback mechanisms using remotely monitored and patient-generated data. Its products include Nutritional Cognitive Behavioral Therapy (Nutritional CBT), behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. It also manufactures therapeutic medicines, such as BTÂ001, BTÂ002, BTÂ003, BTÂ004, and BTÂ005 for cardiometabolic diseases. The company was incorporated in 2015 and is based in San Francisco, California.Where does BTTX stock trade?
Better Therapeutics Inc. (BTTX) is listed on NASDAQ.What sector and industry is BTTX in?
Better Therapeutics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Better Therapeutics Inc. go public?
Better Therapeutics Inc. (BTTX) completed its IPO in 2021.What are analysts saying about BTTX?
Better Therapeutics Inc. has had 2 recent analyst actions on file. The most recent action was from Chardan Capital Markets: Buy with a $1700.00 price target on 2021-11-24. Recent price targets cluster around $1700.00.What companies are similar to BTTX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare BTTX side-by-side with any of them on Quantisnow.How can I track BTTX on Quantisnow?
Quantisnow aggregates Better Therapeutics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BTTX to receive live email and push alerts on every new disclosure.